The company said that it can distinguish patients suffering from lupus from those with other autoimmune diseases using its antibody array platform.
The deal joins Metabolon's metabolomics expertise with InnVentis' big data and machine learning platform.
Contractor Palmetto GBA issued a draft local coverage determination proposing ending coverage of the test based on factors including a recent critical study.
The researchers found that patients with periodontitis exhibited patterns of autoantigen hypercitrullination similar to those found in RA patients.
The studies looked at applications including predicting disease progression, guiding drug tapering, and identifying patients at risk of related conditions.
Results from the Rheumatoid Arthritis Responder Dream Challenge did not support the use of common SNP data to improve treatment response prediction models.
Firalis is developing an assay based on HTG's EdgeSeq platform to identify rheumatoid arthritis patients likely to respond to anti-TNF-alpha therapies.
IQuity's current tests analyze gene expression patterns detected in mRNA, but the firm is also exploring the diagnostic potential of long non-coding RNAs.
The approach can increase CpG coverage about 18-fold by inferring from existing data to predict methylation of sites outside those covered on the arrays themselves.
In PLOS this week: researchers trace inherited cancer syndrome to a German couple born in the 1700s, loci involved in exceptional longevity, and more.
The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.
Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.
In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.
China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.